Therefore, studies of antioxidant and neuroprotector agents that might slow the progression of Alzheimer’s disease (AD) by protecting neurons from oxidative stress and acting as cholinesterase inhibitors have gained increasing interest22. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.